BioCentury
ARTICLE | Company News

CV Therapeutics, Solvay sales and marketing update

October 16, 2006 7:00 AM UTC

The companies terminated their 2004 deal to co-promote SOLB's Aceon perindopril erbumine tablets in the U.S. to treat essential hypertension and to reduce the risk of cardiovascular mortality or non-...